ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,326 | -43.0% | 40,346 | +120.1% | 0.00% | – |
| Q2 2023 | $9,350 | +77816.7% | 18,333 | +0.1% | 0.00% | – |
| Q1 2023 | $12 | 0.0% | 18,307 | +1.4% | 0.00% | – |
| Q4 2022 | $12 | -100.0% | 18,061 | -56.5% | 0.00% | -100.0% |
| Q3 2022 | $71,000 | +610.0% | 41,507 | +443.5% | 0.00% | – |
| Q2 2022 | $10,000 | -9.1% | 7,637 | -55.4% | 0.00% | – |
| Q1 2022 | $11,000 | -21.4% | 17,121 | +37.0% | 0.00% | – |
| Q4 2021 | $14,000 | -50.0% | 12,496 | -17.0% | 0.00% | -100.0% |
| Q3 2021 | $28,000 | -67.4% | 15,054 | -53.8% | 0.00% | -50.0% |
| Q2 2021 | $86,000 | -21.8% | 32,551 | +6.3% | 0.00% | 0.0% |
| Q1 2021 | $110,000 | +115.7% | 30,624 | +53.9% | 0.00% | 0.0% |
| Q4 2020 | $51,000 | -92.8% | 19,894 | -92.9% | 0.00% | -75.0% |
| Q3 2020 | $704,000 | +557.9% | 279,478 | +757.1% | 0.01% | +100.0% |
| Q2 2020 | $107,000 | – | 32,608 | +32508.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 100 | -99.4% | 0.00% | -100.0% |
| Q2 2019 | $101,000 | – | 17,362 | +20325.9% | 0.01% | – |
| Q1 2019 | $0 | – | 85 | -57.5% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 200 | -98.3% | 0.00% | -100.0% |
| Q1 2018 | $47,000 | -68.0% | 12,104 | -49.4% | 0.00% | -66.7% |
| Q3 2017 | $147,000 | +14600.0% | 23,934 | +23834.0% | 0.01% | – |
| Q1 2017 | $1,000 | -98.4% | 100 | -99.1% | 0.00% | -100.0% |
| Q4 2016 | $61,000 | +1120.0% | 11,323 | +1032.3% | 0.01% | – |
| Q2 2016 | $5,000 | -16.7% | 1,000 | +19.9% | 0.00% | -100.0% |
| Q1 2016 | $6,000 | -95.1% | 834 | -93.9% | 0.00% | -91.7% |
| Q3 2015 | $122,000 | -63.0% | 13,562 | -50.7% | 0.01% | -58.6% |
| Q2 2015 | $330,000 | +53.5% | 27,499 | +38.0% | 0.03% | +7.4% |
| Q1 2015 | $215,000 | +1691.7% | 19,930 | +766.5% | 0.03% | +2600.0% |
| Q4 2014 | $12,000 | -40.0% | 2,300 | -69.7% | 0.00% | -50.0% |
| Q3 2014 | $20,000 | -61.5% | 7,579 | -41.8% | 0.00% | -71.4% |
| Q2 2014 | $52,000 | +5100.0% | 13,016 | +6408.0% | 0.01% | – |
| Q1 2014 | $1,000 | -88.9% | 200 | -91.2% | 0.00% | -100.0% |
| Q4 2013 | $9,000 | -84.2% | 2,267 | -84.3% | 0.00% | -66.7% |
| Q3 2013 | $57,000 | +1040.0% | 14,416 | +468.0% | 0.01% | – |
| Q2 2013 | $5,000 | – | 2,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |